MD-TISSUE is designed to:

  • Effectively reduces pain and improves joint and tissue movement (tendons and ligaments)

Composition: Collagen of porcine origin, Ascorbic acid, Magnesium gluconate, Pyridoxine hydrochloride, Riboflavin,
Thiamine hydrochloride, NaCl, Water for injection.

Box: 5 vials (2 ml each)
Box: 10 vials (2 ml each)

Login to see downloads

Corrado B. Use of injectable collagen in partial-thickness tears of the supraspinatus tendon: a case report. Oxford Medical Case Reports, 2020;11,408–410.

Corrado B. et al. Ultrasound-guided collagen injections in the treatment of supraspinatus tendinopathy: a case series pilot study. Advances in in musculoskeletal diseases and infections. Journal of Biological Regulators and Homeostatic Agents. 2020 May-Jun;34(3 Suppl. 2):33-39.

Corrado B. et. al. Treatment of Lateral Epicondylitis with Collagen Injections: a Pilot Study. Muscles, Ligaments, Tendons Journal 2019; 584-589

Ahumada Arredondo O. Epicondylitis − a solution with collagen medical devices. Physiological Regulating Medicine, 2020; 45-55.

Falconi Klein E. Face Revitalization – Biolifting with MD-TISSUE. Physiological Regulating Medicine 2012; 15-20.

Randelli F. et al. Effect of a Collagen-Based Medical Compound on Morpho-Functional Properties of Cultured Human Tenocytes”, Cells 2018 Dec 6;7(12).

Randelli F. et al. Characterization of collagen turnover in human tenocytes cultured on the collagen-based medical device MD-TISSUE. La Medicina Biologica, 2018/4; 67-68.

Randelli F. et al. The Collagen-Based Medical Device MD-Tissue Acts as a Mechanical Scaffold Influencing Morpho-Functional Properties of Cultured Human Tenocytes. Cells. 2020 Dec;9(12). DOI: 10.3390/cells9122641

Related Product


Register to the reserved area to access exclusive product content and informative materials.